Free Account Opening + AMC Free Demat
Loading...

Ajanta Pharma Buyback vs Emami Ltd Buyback

Comparision between Ajanta Pharma Buyback and Emami Ltd Buyback.

Buyback Details

Ajanta Pharma Buyback is a Tender Offer buyback proposed to list at BSE, NSE while Emami Ltd Buyback is a Open Market Through Stock Exchange proposed to list at BSE, NSE.

  Ajanta Pharma Limited Emami Limited
Logo Ajanta Pharma Buyback Logo Emami Ltd Buyback Logo
Type of Buyback Tender Offer Open Market Through Stock Exchange
Listing At BSE, NSE BSE, NSE
Face Value ₹2 per share ₹1 per share
Buyback Price ₹2550 per share ₹550 per share
Issue Size 11,20,000 shares
Issue Size (Amount) ₹285.60 Crores ₹162.00 Crores
Buyback Ratio
Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 30 Equity Shares out of every 151 shares held on the record date.
General Category for all other Eligible Shareholders 1 Equity Shares out of every 91 shares held on the record date.
Registrar Link Intime India Private Ltd Maheshwari Datamatics Pvt. Ltd
Lead Managers Vivro Financial Services Private Limited Iifl Securities Ltd
Necessity of the buyback

The Buyback aims to :
i) Distribute surplus funds to shareholders and thereby enhance their overall return.
ii) Improve financial ratios like Earnings per share (EPS), Return on assets (ROA) and Return on Equity (ROE).

The Buyback aims to :
i) Return surplus cash to its Shareholders.
ii) Reduce the outstanding number of equity shares and consequently increase earnings per share and book value per share.
iii) Improve key return ratios like return on equity capital.

Buyback Timetable

Ajanta Pharma Buyback and Emami Ltd Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Ajanta Pharma Buyback Buyback record date is Jan 14, 2022. Emami Ltd Buyback Buyback record date is .

  Ajanta Pharma Limited Emami Limited
Record Date Jan 14, 2022
Offer Open Date Feb 03, 2022 Feb 09, 2022
Offer Closure Date Feb 16, 2022 Aug 08, 2022
Last date for receipt of tender forms Feb 16, 2022
Finalisation of buyback Feb 24, 2022
Last Date for settlment of bids Feb 25, 2022
Last Date for extinguishment of shares Mar 04, 2022

Financial Details and Other Relevent Information

Comparison of Ajanta Pharma Buyback and Emami Ltd Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Ajanta Pharma Limited Emami Limited
Financial
Summary of financial Information Consolidated)
Particulars For the year/period ended (Rs. in Crores)
  30-Sep-21 31-Mar-21 31-Mar-20
Total Income 1,694.96 2,915.67 2,680.06
Profit After Tax 369.69 653.87 467.70
Net Worth 3,358.90 2,995.63 2,598.87
Reserves and Surplus 3,341.51 2,978.24 2,581.33
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Millions)
31-Mar-21 31-Mar-20 31-Mar-19
Total Income 29,508.00 27,119.50 27,295.30
Profit After Tax 4,547.10 3,023.00 3,025.30
Net Worth 17,626.50 18,237.50 20,760.60
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2021 2239.10 2015.80 2136.74
Oct-2021 2366.30 2053.65 2213.24
Sep-2021 2340.00 2112.70 2199.31

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2022 535.00 466.05 499.89
Dec-2021 555.00 504.00 536.24
Nov-2021 578.65 502.80 537.45
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2021 2239.10 2000.00 2137.44
Oct-2021 2365.80 2053.65 2213.37
Sep-2021 2330.00 2110.00 2201.05

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2022 534.80 466.00 497.73
Dec-2021 555.00 504.05 528.04
Nov-2021 578.50 503.00 537.48

Comments

Add a public comment...